The proposed bill aims to limit cost-sharing for prescription drugs and related medical supplies used to treat chronic diseases in Minnesota. It introduces a new section, [62Q.481], which mandates that health plans must cap the cost-sharing for prescription drugs at $25 per one-month supply and $50 per month for all related medical supplies, regardless of the number of chronic diseases an enrollee has. The bill specifies that this coverage will not be subject to any deductible and outlines the definitions of "chronic disease," "cost-sharing," and "related medical supplies." The effective date for these provisions is set for January 1, 2024.

Additionally, the bill amends existing statutes, specifically sections 256B.0631 and 256L.03, to incorporate the new cost-sharing requirements for chronic disease treatments. It adds a clause stating that cost-sharing for prescription drugs and related medical supplies must comply with the new section [62Q.481]. The amendments also clarify that the effective date for these changes aligns with the new provisions, ensuring that the updated cost-sharing limits will be in effect starting January 1, 2024.

Statutes affected:
1st Engrossment: 256B.0631, 256L.03
1st Engrossment: 256B.0631, 256L.03